NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Valneva SE (PA: VLA)

 
VLA Technical Analysis
5
As on 9th Jun 2023 VLA SHARE Price closed @ 6.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 11.36 & Strong Sell for SHORT-TERM with Stoploss of 15.90 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VLASHARE Price

Open 5.90 Change Price %
High 6.11 1 Day 0.09 1.51
Low 5.89 1 Week 0.84 16.12
Close 6.05 1 Month 1.69 38.76
Volume 392142 1 Year -18.45 -75.31
52 Week High 24.68 | 52 Week Low 4.21
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALDRV 0.01 0.00%
AF 1.73 1.76%
CGG 0.69 -2.82%
ALVMG 0.50 0.00%
ACA 10.83 -0.91%
ALJXR 0.01 0.00%
CS 26.52 -2.00%
GLE 23.32 1.92%
 
PA France Top Gainers Stocks
ALAGP 5.50 13.40%
ALSEN 0.32 10.34%
MLPAP 0.55 10.00%
ALMAR 1.15 9.52%
CO 6.03 8.84%
CO 6.03 8.84%
CO 6.03 8.84%
ALGAU 1.92 8.47%
2MX 7.46 8.43%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLWEL 0.23 -28.12%
ALPHA 0.08 -27.27%
ALPHA 0.08 -27.27%
MLCLP 4.48 -25.95%
ALHYG 0.05 -16.67%
ALLIX 10.80 -13.60%
MLERO 2.52 -12.50%
 
 
VLA
Daily Charts
VLA
Intraday Charts
Whats New @
Bazaartrend
VLA
Free Analysis
 
VLA Important Levels Intraday
RESISTANCE6.47
RESISTANCE6.34
RESISTANCE6.25
RESISTANCE6.17
SUPPORT5.93
SUPPORT5.85
SUPPORT5.76
SUPPORT5.63
 
VLA Forecast April 2024
4th UP Forecast16.26
3rd UP Forecast12.99
2nd UP Forecast10.96
1st UP Forecast8.94
1st DOWN Forecast3.16
2nd DOWN Forecast1.14
3rd DOWN Forecast-0.89
4th DOWN Forecast-4.16
 
VLA Weekly Forecast
4th UP Forecast12.76
3rd UP Forecast10.61
2nd UP Forecast9.28
1st UP Forecast7.95
1st DOWN Forecast4.15
2nd DOWN Forecast2.82
3rd DOWN Forecast1.49
4th DOWN Forecast-0.66
 
VLA Forecast2024
4th UP Forecast44.96
3rd UP Forecast32.48
2nd UP Forecast24.77
1st UP Forecast17.05
1st DOWN Forecast-4.95
2nd DOWN Forecast-12.67
3rd DOWN Forecast-20.38
4th DOWN Forecast-32.86
 
 
VLA Other Details
Segment EQ
Market Capital 2033237248.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VLA Address
VLA
 
VLA Latest News
 
Your Comments and Response on Valneva SE
 
VLA Business Profile
Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; and DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium. The company also develops VLA15, a vaccine candidate that is in Phase II clinical trial against Borrelia; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; and VLA2001, a vaccine candidate that has completed Phase I/II clinical trial against SARS-CoV-2. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, other European countries, and internationally. The company has collaborations with Pfizer to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. Valneva SE was incorporated in 1999 and is headquartered in Saint-Herblain, France. Address: 6 rue Alain Bombard, Saint-Herblain, France, 44800
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service